Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

IBM Watson Health

- PMLiVE

Novartis buys gene therapy firm AveXis for $8.7bn

Lead candidate AVXS-101 could potentially replace regular drug treatment for SMA with a one-off intervention

- PMLiVE

Health insurers will test blockchain for data handling

Aims to make health records more accurate and reliable

- PMLiVE

Life science companies can’t keep up with technology competitors

The industry must look beyond novel drugs and devices, warns report

- PMLiVE

Merck KGaA inks deal for Medisafe adherence app

The digital programme will be initially rolled out in Brazil, Russia and Mexico

- PMLiVE

GSK buys Novartis out of consumer health JV after ditching Pfizer bid

Will pay $13bn for the 36.5% stake owned by the Swiss drug maker

- PMLiVE

Can value-based healthcare take off and reach for the skies?

Are companies willing to contribute to the change in the healthcare system?

Bayer looks to leverage AI across the pharma value chain

Dieter Weinand outlines his hopes for applying artificial intelligence

- PMLiVE

Healthcare sector ‘lacks awareness’ of cybersecurity threats

RAE report suggests medical devices could be prone to cyber attacks

Investing in digital could ‘unlock £22bn’ for UK pharma

Accenture outlines tech's revenue-growth and cost-saving potential

- PMLiVE

Novartis pushes ‘virtual’ clinical trial concept

Teams up with Science 37 to run ten digital-based trials over the next three years

‘Femtech’ poised to explode, with applications set to trigger healthcare disruption

Will be driven by strong funding and positive regulatory environment

BenevolentAI claims AI first with new Cambridge facility

Says its new drug discovery and development base will cover the entire research process

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links